GlassScriptPhysician profile
Harrison M Cotler
NPI 1679969950
$149,450.09
in general payments reported to CMS, 2019-2025
42 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $223 · 2021: $4,687 · 2022: $35K · 2023: $21K · 2024: $60K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Travel and Lodging: $40K · Food and Beverage: $8,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,440.00 |
| Travel and Lodging | $39,624.25 |
| Food and Beverage | $8,508.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $138,929.31 | 2021-2025 | Integra, Cytal, Integra Dermal Regeneration Template |
| Intuitive Surgical, INC. | $3,581.60 | 2021-2024 | |
| Tela Bio, INC. | $3,335.29 | 2021-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $817.95 | 2021-2025 | Arista Ah Flexitip, Channel Drain, Phasix Mesh |
| Dilon Technologies, INC. | $479.14 | 2024 | Hemoblast Bellows |
| Stryker Corporation | $165.04 | 2022 | |
| Amgen INC. | $149.66 | 2024 | Tavneos |
| Baxter Healthcare | $145.63 | 2023 | |
| Smith+Nephew, INC. | $141.25 | 2021-2025 | Renasys Go V2 Home, Collagenase Santyl, Renasys Touch |
| Astrazeneca Pharmaceuticals LP | $132.55 | 2020-2021 | |
| Boston Scientific Corporation | $126.89 | 2022-2024 | Exalt Model D |
| Baudax Bio INC. | $125.00 | 2021 | |
| Genzyme Corporation | $124.99 | 2025 | |
| Janssen Pharmaceuticals, INC | $117.81 | 2020 | |
| Innovation Technologies INC | $107.02 | 2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $92.37 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $85.41 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $69.81 | 2022-2023 | Seglentis |
| Sanara Medtech INC. | $63.34 | 2024-2025 | Celleraterx, Biasurge |
| Innocoll Pharmaceuticals Limited | $62.46 | 2021-2022 | |
| Biotissue Holdings INC. | $60.34 | 2023 | |
| Acera Surgical, INC. | $54.64 | 2022-2025 | Restrata Wound Matrix |
| Avita Medical Americas, LLC | $51.48 | 2023-2024 | Recell |
| Conmed Corporation | $44.05 | 2025 | Airseal |
| Merck Sharp & Dohme LLC | $42.34 | 2024 | Bridion |
| Eisai INC. | $38.24 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $36.70 | 2022 | |
| Lifenet Health | $32.45 | 2025 | Theragenesis Wound Matrix |
| Ethicon US, LLC | $32.30 | 2021 | |
| Reprise Biomedical, INC. | $30.30 | 2021-2023 | Miro3d, Miro3d Fibers |
| Solventum Corporation | $19.19 | 2024 | V.A.C.Ulta, Abthera |
| Medtronic, INC. | $18.37 | 2021 | |
| Abbvie INC. | $15.45 | 2022 | |
| Convatec INC. | $14.90 | 2023 | |
| Axonics, INC. | $14.33 | 2021 | |
| Acell, INC. | $14.30 | 2020 | |
| Lundbeck LLC | $13.89 | 2020 | |
| Abbott Laboratories | $13.39 | 2023 | Freestyle Libre 3 |
| Olympus America INC. | $13.23 | 2021 | |
| Amarin Pharma, INC. | $12.67 | 2020 | |
| Misonix INC | $12.51 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Cotler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.